Publications by authors named "Manju Sengar"

Claim this Profile
E
Expert insights: 10 key questions on managing common infections in cancer care in India.
Lingaraj Nayak, Gaurav Salunke, Trupti Gilada, Sukhada Savarkar, Bindiya Salunke, Manju Sengar

Ecancermedicalscience· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India.
George John, Sumeet Mirgh, Sachin Punatar, Nishant Jindal, Lingaraj Nayak, Manju Sengar

EJHaem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India.
Srobana Ghosh, C S Pramesh, Manju Sengar, Priya Ranganathan, Francis Ruiz

BMJ Evid Based Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunotherapy-a wolf in sheep's clothing?
Roni Levin, Amol Akhade, Manju Sengar, Daniel A Goldstein

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provincialising Global Oncology.
Nickolas Surawy Stepney, Shagufta Bhangu, Henry Llewellyn, Jennifer Fraser, Thandeka Cochrane, Manju Sengar

BMJ Glob Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines.
Brooke E Wilson, Kristin Wright, Manju Sengar, Richard Sullivan, Sallie-Anne Pearson

J Natl Cancer Inst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.
Mark N Sorial, Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Sijia Li, Manju Sengar

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a CAR-T cell therapy program in India.
Hema Hotchandani, Manju Sengar, Alok Shetty, Anupa John, Atharva Karulkar

Expert Rev Anticancer Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the potential financial impacts of expanding access to immune checkpoint inhibitors as monotherapy for treating advanced non-small cell lung cancer.
Kiu Tay-Teo, Dario Trapani, Manju Sengar, Zeba Aziz, Filip Meheus

EClinicalMedicine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative Care Needs in Adult Patients with Acute Leukemia: A Prospective Observational Study.
Jyothsna Kuriakose, Jayita K Deodhar, Hasmukh Jain, Manju Sengar, Alok Shetty

J Palliat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Cancer Grid initiative for electronic medical records, India.
C S Pramesh, Rizwan Koita, Manju Sengar, Nikesh Shah, Anthony Vipin Das

Bull World Health Organ· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, Sachin Punatar, Akanksha Chichra, Manju Sengar

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study.
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Shreshtha Shah, Manju Sengar

Lancet Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, Sachin Punatar, Akanksha Chichra, Manju Sengar

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population.
Hasmukh Jain, Thomas Eipe, Alok Shetty, Lingaraj Nayak, Bhausaheb Pandurang Bagal, Manju Sengar

JCO Glob Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Wafik S El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A Carneiro, Don S Dizon, Manju Sengar

Oncotarget· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.
Akhil Rajendra, Manju Sengar, Anu Korula, Prasanth Ganesan, Hasmukh Jain

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.
Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Mark Sorial, Sean M McCabe, Manju Sengar

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAPID-CRISPR: highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia.
Akash Maity, Amritha Sathyanarayanan, Rohit Kumar, Jesal Vora, Jitendra Gawde, Manju Sengar

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials.
Bishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, Christopher M Booth, Nathan I Cherny, Manju Sengar

Lancet Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health benefits package selection in oncology: a clinical audit of palliative chemotherapy for breast cancer in an Indian health insurance scheme.
Sebastian Bauhoff, Manju Sengar, C S Pramesh, Anamika Dhiman, Abha Mehndiratta

BMC Health Serv Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India.
Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak, Hasmukh Jain, Uday Kulkarni, Manju Sengar

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre.
Rup Jyoti Sarma, Lakhan Kashyap, Anne Srikanth, Tanmoy Mondal, Yashwant Kashyap, Manju Sengar

Indian J Hematol Blood Transfus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANCER Care in COVID-19 ERA: A Prospective Survey to Study the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India.
Surabhi Bhat, Avinash Bonda, Manju Sengar, Jayashree Thorat, Bhausaheb Bagal

Indian J Hematol Blood Transfus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of hepatitis B and hepatitis C-related cancers in India.
Sivaranjini Kannusamy, Amey Oak, Sandhya Cheulkar, Kamesh Maske, Esha Dashmukhe, Manju Sengar

Ecancermedicalscience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis